These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1397884)

  • 21. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients.
    Mostafa T; Badra G; Abdallah M
    Turk J Gastroenterol; 2015 Mar; 26(2):163-9. PubMed ID: 25835116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients].
    Soriano G; Guarner C; Tomás A; Anguera A; Mirelis B; Fernández C; Herrero M; Alonso C; Vilardell F
    Rev Esp Enferm Dig; 1992 May; 81(5):322-6. PubMed ID: 1616740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
    Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
    Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
    Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
    Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study.
    Ulrich C; Harinck-de Weerd JE; Bakker NC; Jacz K; Doornbos L; de Ridder VA
    Intensive Care Med; 1989; 15(7):424-31. PubMed ID: 2689493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Itha S; Sharma A; Bhatt G
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
    [No Abstract]   [Full Text] [Related]  

  • 28. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.
    Marciano S; Dirchwolf M; Diaz JM; Bermudez C; Gutierrez-Acevedo MN; Barcán LA; Smud A; Giunta D; Gadano AC
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):540-546. PubMed ID: 30557229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
    Bernard B; Grangé JD; Khac EN; Amiot X; Opolon P; Poynard T
    Hepatology; 1999 Jun; 29(6):1655-61. PubMed ID: 10347104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage.
    Rimola A; Bory F; Teres J; Perez-Ayuso RM; Arroyo V; Rodes J
    Hepatology; 1985; 5(3):463-7. PubMed ID: 3873389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
    Hong SN; Kim BJ; Lee SY; Lee CY; Ryu MK; Choi MS; Lee JH; Rhee PL; Koh KC; Kim JJ; Paik SW; Rhee JC; Choi KW
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):288-96. PubMed ID: 12499786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis.
    Younossi ZM; McHutchison JG; Ganiats TG
    J Hepatol; 1997 Aug; 27(2):295-8. PubMed ID: 9288603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Wiesneth M; Bunjes D; Hertenstein B; Kern W; Heit W; Heimpel H
    Scand J Infect Dis; 1988; 20(6):625-31. PubMed ID: 3065930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis.
    Juanola O; Gómez-Hurtado I; Zapater P; Moratalla A; Caparrós E; Piñero P; González-Navajas JM; Giménez P; Such J; Francés R
    Liver Int; 2016 Dec; 36(12):1811-1820. PubMed ID: 27214392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis?
    Schubert ML; Sanyal AJ; Wong ES
    Gastroenterology; 1991 Aug; 101(2):550-2. PubMed ID: 1906029
    [No Abstract]   [Full Text] [Related]  

  • 37. Current aspects of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhosis patients.
    Almeida D; Paraná R
    Braz J Infect Dis; 2002 Oct; 6(5):266-8. PubMed ID: 12495610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
    Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
    Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.
    Winston DJ; Ho WG; Nakao SL; Gale RP; Champlin RE
    Am J Med; 1986 May; 80(5):884-90. PubMed ID: 3010716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.